Superworth

Wave Life Sciences EPS WVE

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
−$1.09
Latest quarter, Q2 FY26
−$0.34
Fiscal year 2025
−$1.22

Wave Life Sciences' earnings per share was −$1.09 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.34.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.22n/a
FY2024−$0.78n/a
FY2023−$0.55n/a
FY2022−$2.13n/a
FY2021−$2.37n/a
FY2020−$3.98n/a
FY2019−$5.71n/a
FY2018−$5.06n/a
FY2017−$3.84n/a
FY2016−$2.41n/a
FY2015−$1.82n/a
FY2014n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.34n/a−$1.09
Q1 FY26−$0.13n/a−$1.06
Q4 FY25−$0.30−267%−$1.22
Q3 FY25−$0.32n/a−$0.74
Q2 FY25−$0.31n/a−$0.89
Q1 FY25−$0.29n/a−$0.83
Q4 FY24$0.18n/a−$0.78
Q3 FY24−$0.47−771%−$1.11
Q2 FY24−$0.25n/a−$0.57
Q1 FY24−$0.24n/a−$0.52
Q4 FY23−$0.15n/a−$0.55
Q3 FY23$0.07n/a−$0.87

Against its peers

Companies in Drug Manufacturers - General nearest Wave Life Sciences' size, closest first, today.

CompanyEPS, 12 monthsGrowth
WVEWave Life Sciences−$1.09
CRMDCorMedix$2.13+184% a year
ZVRAZevra Therapeutics$0.93
IRWDIronwood Pharmaceuticals$0.77
PBYIPuma Biotechnology$0.52−47% a year
COLLCollegium Pharmaceutical$1.24+19% a year
ARVNArvinas$0.16
ABUSArbutus Biopharma$0.78
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OMEROmeros$1.52
PCRXPacira BioSciences$0.35
Peer median$0.85

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Wave Life Sciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.